Solid Biosciences Inc. Basic Shares Outstanding (Weighted Average)
Solid Biosciences Inc. (SLDB) reported Basic Shares Outstanding (Weighted Average) of 143.69 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-06
- Solid Biosciences Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 143.69M shares, a 52.63% increase year-over-year.
- Solid Biosciences Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 109.81M shares, a 65.53% increase year-over-year.
- Solid Biosciences Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 94.81M shares, a 121.94% increase year-over-year.
- Solid Biosciences Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 94.42M shares, a 127.82% increase year-over-year.
- Solid Biosciences Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 87.50M shares, a 114.38% increase from fiscal 2024.
- Solid Biosciences Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 40.82M shares, a 105.27% increase from fiscal 2023.
- Solid Biosciences Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 19.88M shares, a 133.60% increase from fiscal 2022.
- Solid Biosciences Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 8.51M shares, a 19.58% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | 143.69M shares 10-Q · filed 2026-08-06 | 126.84M shares 10-Q · filed 2026-08-06 | 116.10M shares derived: average of 3 quarters · filed 2026-08-06 | 110.68M shares derived: average of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | 109.81M shares 10-Q · filed 2026-05-12 | 102.31M shares derived: average of 2 quarters · filed 2026-05-12 | 99.68M shares derived: average of 3 quarters · filed 2026-05-12 | 98.30M shares derived: average of 4 quarters · filed 2026-08-06 | ||
| 2025-12-31 | 94.81M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | 94.61M shares derived: average of 2 quarters · filed 2026-03-19 | 94.46M shares derived: average of 3 quarters · filed 2026-08-06 | 87.50M shares 10-K · filed 2026-03-19 | ||
| 2025-09-30 | 94.42M shares 10-Q · filed 2025-11-03 | 94.28M shares derived: average of 2 quarters · filed 2026-08-06 | 85.07M shares 10-Q · filed 2025-11-03 | 74.40M shares derived: average of 4 quarters · filed 2026-08-06 | ||
| 2025-06-30 | 94.14M shares 10-Q · filed 2026-08-06 | 80.32M shares 10-Q · filed 2026-08-06 | 67.73M shares derived: average of 3 quarters · filed 2026-08-06 | 61.16M shares derived: average of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | 66.34M shares 10-Q · filed 2026-05-12 | 54.53M shares derived: average of 2 quarters · filed 2026-05-12 | 50.17M shares derived: average of 3 quarters · filed 2026-05-12 | 47.86M shares derived: average of 4 quarters · filed 2026-05-12 | ||
| 2024-12-31 | 42.72M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | 42.08M shares derived: average of 2 quarters · filed 2026-03-19 | 41.70M shares derived: average of 3 quarters · filed 2026-03-19 | 40.82M shares 10-K · filed 2026-03-19 | ||
| 2024-09-30 | 41.44M shares 10-Q · filed 2025-11-03 | 41.19M shares derived: average of 2 quarters · filed 2025-11-03 | 40.18M shares 10-Q · filed 2025-11-03 | 35.19M shares derived: average of 4 quarters · filed 2025-11-03 | ||
| 2024-06-30 | 40.93M shares 10-Q · filed 2025-08-12 | 39.54M shares 10-Q · filed 2025-08-12 | 33.11M shares derived: average of 3 quarters · filed 2025-08-12 | 29.85M shares derived: average of 4 quarters · filed 2025-08-12 | ||
| 2024-03-31 | 38.16M shares 10-Q · filed 2025-05-15 | 29.19M shares derived: average of 2 quarters · filed 2025-05-15 | 26.15M shares derived: average of 3 quarters · filed 2025-05-15 | 24.53M shares derived: average of 4 quarters · filed 2025-05-15 | ||
| 2023-12-31 | 20.23M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | 20.15M shares derived: average of 2 quarters · filed 2025-03-06 | 19.99M shares derived: average of 3 quarters · filed 2025-03-06 | 19.88M shares 10-K · filed 2025-03-06 | ||
| 2023-09-30 | 20.06M shares 10-Q · filed 2024-11-06 | 19.86M shares derived: average of 2 quarters · filed 2024-11-06 | 19.77M shares 10-Q · filed 2024-11-06 | 17.69M shares derived: average of 4 quarters · filed 2024-11-06 | ||
| 2023-06-30 | 19.66M shares 10-Q · filed 2024-08-13 | 19.62M shares 10-Q · filed 2024-08-13 | 16.91M shares derived: average of 3 quarters · filed 2024-08-13 | 14.56M shares derived: average of 4 quarters · filed 2024-08-13 | ||
| 2023-03-31 | 19.57M shares 10-Q · filed 2024-05-15 | 15.53M shares derived: average of 2 quarters · filed 2024-05-15 | 12.86M shares derived: average of 3 quarters · filed 2024-05-15 | 11.53M shares derived: average of 4 quarters · filed 2024-05-15 | ||
| 2022-12-31 | 11.48M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | 9.51M shares derived: average of 2 quarters · filed 2024-03-13 | 8.85M shares derived: average of 3 quarters · filed 2024-03-13 | 8.51M shares 10-K · filed 2024-03-13 | ||
| 2022-09-30 | 7.53M shares 10-Q · filed 2023-11-08 | 7.53M shares derived: average of 2 quarters · filed 2023-11-08 | 7.52M shares 10-Q · filed 2023-11-08 | 7.52M shares derived: average of 4 quarters · filed 2024-03-13 | ||
| 2022-06-30 | 7.52M shares 10-Q · filed 2023-08-14 | 112.86M shares 10-Q · filed 2022-08-11 | 7.52M shares 10-Q · filed 2023-08-14 | 112.74M shares 10-Q · filed 2022-08-11 | 7.52M shares derived: average of 3 quarters · filed 2024-03-13 | 7.51M shares derived: average of 4 quarters · filed 2024-03-13 |
| 2022-03-31 | 7.51M shares 10-Q · filed 2023-05-11 | 7.52M shares derived: average of 2 quarters · filed 2024-03-13 | 7.51M shares derived: average of 3 quarters · filed 2024-03-13 | 33.71M shares derived: average of 4 quarters · filed 2024-03-13 | ||
| 2021-12-31 | 7.53M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | 7.51M shares derived: average of 2 quarters · filed 2024-03-13 | 42.44M shares derived: average of 3 quarters · filed 2024-03-13 | 7.12M shares 10-K · filed 2024-03-13 | ||
| 2021-09-30 | 7.49M shares 10-Q · filed 2022-11-10 | 59.89M shares derived: average of 2 quarters · filed 2022-11-10 | 6.98M shares 10-Q · filed 2022-11-10 | |||
| 2021-06-30 | 112.30M shares 10-Q · filed 2022-08-11 | 100.85M shares 10-Q · filed 2022-08-11 | ||||
| 2020-12-31 | 3.46M shares 10-K · filed 2023-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |